Trial Profile
A Study of the Utility of Botulinum Toxin Type A for Pain in Advanced Parkinson's Disease Double Blind Placebo Control Crossover Pilot Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Central pain; Dystonia; Musculoskeletal pain
- Focus Therapeutic Use
- 26 Jun 2015 New trial record